Roles of mTORC1 and mTORC2 in regulating metabolic diseases, cancer, and aging

The roles of mTORC1 and mTORC2 in regulating metabolic diseases, cancer, and aging. Differential mTORC1 activity has been shown to be protective against diabetes and cancer, in addition to prolonging life span (top panel). mTORC1 hyperactivity hampers the production of ketone bodies in the liver, protecting against diabetic ketogenesis. In contrast, a reduction in mTORC1 activity promotes the accumulation of senescent cells due to the downregulation of S6K1 and upregulation of PD-L1, which in turn triggers autophagy, slowing the aging process. Moreover, increased levels of NLRC3 due to reduced mTORC1 signaling exert inhibitory effects against cancer, further improving overall health. However, hyperactivation of both mTORC1 and mTORC2 induces progressive outcomes towards metabolic diseases and cancers (bottom panel). Increased activities of both furin and IRS-1 due to continuous mTORC1 activation cause high glucose levels, reduced GSIS, and promote insulin resistance. Taken together, such disruptions directly contribute to β-cell dysfunction, and eventually, diabetes. Increased TGs and lower LDL promote the accumulation of lipid droplets, leading to obesity in a mTORC1-SNAT2-dependent manner. Inhibiting autophagy also plays a role in exacerbating metabolic outcomes that lead to NAFLD driven by eIF4E. Moreover, the crosstalk between both mTOR complexes has also been shown to further inhibit the autophagic pathway, leading to cancer. mTORC2 hyperactivation, due to PTEN loss, leads to continuous cell proliferation, further driving cancer progression. mTORC1 and 2, mammalian target of rapamycin complex 1 and 2; S6K1, P70-S6K1; PD-L1, programmed death-ligand 1; NLRC3, nucleotide-binding domain and leucine-rich repeats 3; IRS-1, insulin receptor substrate 1; SNAT2, sodium-coupled neutral amino acid transporter 2; eIF4E, eukaryotic translation initiation factor 4E; PTEN, phosphatase and tensin homolog; Glu, glucose; GSIS; glucose-stimulated insulin secretion; IR, insulin resistance; TG, triglyceride; LDL, lipoprotein lipase; NAFLD, nonalcoholic fatty liver disease (Created with BioRender.com accessed on 25 May 2024)
Roles of mTORC1 and mTORC2 in regulating metabolic diseases, cancer, and aging

Publication

mTOR: Its Critical Role in Metabolic Diseases, Cancer, and the Aging Process (2024) Sulaiman K. Marafie, et al. Int J Mol Sci. 2024 Jun;25(11). Figure: F2.

Gene mentions


Organism Group Word Match Source NCBI Symbol NCBI ID
Homo sapiens Primates mTORC1 MTORC1 famplex_relations MTOR 2475
Homo sapiens Primates mTORC1 MTORC1 famplex_relations RPTOR 57521
Homo sapiens Primates PD-L1 PD-L1 ncbigene_synonym CD274 29126
Homo sapiens Primates S6K1 S6K1 ncbigene_synonym RPS6KB1 6198
Homo sapiens Primates NLRC3 NLRC3 ncbigene_symbol NLRC3 197358
Homo sapiens Primates mTORC2 MTORC2 famplex_relations MAPKAP1 79109
Homo sapiens Primates mTORC2 MTORC2 famplex_relations RICTOR 253260
Homo sapiens Primates mTORC2 MTORC2 famplex_relations MLST8 64223
Homo sapiens Primates Furin FURIN ncbigene_symbol FURIN 5045
Homo sapiens Primates IRS-1 IRS1 ncbigene_symbol IRS1 3667
Homo sapiens Primates SNAT2 SNAT2 ncbigene_synonym SLC38A2 54407
Homo sapiens Primates eIF4E EIF4E ncbigene_symbol EIF4E 1977
Homo sapiens Primates eIF4E EIF4E famplex_relations EIF4E2 9470
Homo sapiens Primates eIF4E EIF4E famplex_relations EIF4E3 317649
Homo sapiens Primates PTEN PTEN ncbigene_symbol PTEN 5728
Homo sapiens Primates TG TG ncbigene_symbol TG 7038

Chemical mentions

Word Match MeSH Name ChEBI
Ketone Ketone ketones chebi:17087
Lipid Lipid lipids chebi:18059

Disease mentions

Word Match MeSH Name DOID
Cancer cancer cancer DOID:162
Obesity obesity obesity DOID:9970
Cancer cancer cancer DOID:162